Quarterly report pursuant to Section 13 or 15(d)

Statement of Operations

v2.4.0.6
Statement of Operations (USD $)
 3 Months Ended 144 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Expenses:      
General and administrative $ 1,210,752 $ 728,172 $ 31,270,896
Research and development 552,466 1,042,700 35,830,965
Patent fees 136,491 102,589 2,668,595
Depreciation and amortization 9,316 10,721 692,239
Total Expenses 1,909,025 1,884,182 70,462,695
Loss from Operations (1,909,025) (1,884,182) (70,462,695)
Other Income (Expense)      
Realized loss on marketable securities     (13,301)
Interest income 10,018 6,249 1,452,417
Interest expense     (301,147)
Other income     56,047
Unrealized gain (loss) on fair value of warrants 368,902 (261,861) 4,708,883
Unrealized gain on fair value of put feature on common stock     2,315,539
Financing expense     (972,131)
Beneficial conversion feature     (1,625,000)
Total Other Income (Expense) 378,920 (255,612) 5,621,307
Net Loss Before Provision for Income Taxes (1,530,105) (2,139,794) (64,841,388)
Net Loss $ (1,530,105) $ (2,139,794) $ (64,841,388)
Net loss per share, basic and diluted $ (0.01) $ (0.02)  
Weighted average number of shares outstanding, basic and diluted 119,428,989 95,345,656